Found: 6
Select item for more details and to access through your institution.
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2049, doi. 10.3390/cancers12082049
- By:
- Publication type:
- Article
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47627-1
- By:
- Publication type:
- Article
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma.
- Published in:
- Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.661102
- By:
- Publication type:
- Article
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.672287
- By:
- Publication type:
- Article
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 6, p. 1064, doi. 10.1007/s10120-020-01078-0
- By:
- Publication type:
- Article